About IPEC - Instituto de Pesquisa Clínica
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Allergan
2
Eli Lilly and Company
2
Eurofarma Laboratorios S.A.
1
Janssen Research & Development, LLC
1
Clinical Trials at IPEC - Instituto de Pesquisa Clínica
During the past decade, IPEC - Instituto de Pesquisa Clínica conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Evogliptin in Type 2 Diabetes Mellitus (EVOLUTION: EVOgLiptina no Diabetes Mellitus TIpO 2)
2017-08-08
2018-08-09
Completed
146
A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to <18 Years) With Type 2 Diabetes Mellitus
2017-07-21
2023-10-01
Active, not recruiting
171
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 04
2018-02-01
2020-11-05
Terminated
450
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
2018-01-24
2020-10-30
Terminated
467
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
2020-05-29
2024-10-17
Active, not recruiting
13,299
A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin
2020-10-19
2022-11-01
Completed
1,428
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at IPEC - Instituto de Pesquisa Clínica
According to Clinical.Site data, the most researched conditions in "IPEC - Instituto de Pesquisa Clínica" are
"Diabetes Mellitus" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Gastroparesis" (2 trials), "Type 2 Diabetes" (1 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "IPEC - Instituto de Pesquisa Clínica" in a lesser frequency.
Clinical Trials Intervention Types at IPEC - Instituto de Pesquisa Clínica
Most popular intervention types in "IPEC - Instituto de Pesquisa Clínica" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Relamorelin" (2 trials), "Tirzepatide" (2 trials), "Canagliflozin 100 mg" (1 trials) and "Canagliflozin 300 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at IPEC - Instituto de Pesquisa Clínica
The vast majority of trials in "IPEC - Instituto de Pesquisa Clínica" are
6 trials for "All" genders.
Clinical Trials Status at IPEC - Instituto de Pesquisa Clínica
Currently, there are NaN active trials in "IPEC - Instituto de Pesquisa Clínica".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in IPEC - Instituto de Pesquisa Clínica,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in IPEC - Instituto de Pesquisa Clínica, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".